Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery

ClinicalTrials.gov ID: NCT05486416

Public ClinicalTrials.gov record NCT05486416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Global Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to Propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additional 1.0 mg/kg if needed) in success of induction of general anesthesia in adults undergoing elective surgery.

Study identification

NCT ID
NCT05486416
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
465 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2024 (Actual)
Primary completion
Jul 23, 2024 (Actual)
Completion
Jul 23, 2024 (Actual)
Last update posted
Oct 10, 2025

2024

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
North Alabama Medical Center Florence Alabama 35630 —
Helen Keller Hospital Sheffield Alabama 35660 —
University of Miami Hospital Miami Florida 33136 —
Gulfcoast Research Institute Sarasota Florida 34232 —
Phoenix Clinical Research, LLC Tamarac Florida 33321 —
ForCare Clinical Research Tampa Florida 33613 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
EBGS Clinical Research Center Snellville Georgia 30078 —
University of Iowa Hospitals and Clinics (Dept of Anesthesia) Iowa City Iowa 52242 —
U of L Health, University of Louisville Hospital Louisville Kentucky 40202 —
The Brigham and Women's Hospital Boston Massachusetts 02115 —
Michigan Medicine Ann Arbor Michigan 48109 —
M3-Emerging Medical Research, LLC Durham North Carolina 27704 —
Duke University Medical Center (DUMC) Durham North Carolina 27710 —
The Ohio State University Wexner Medical Center - University Hospital Columbus Ohio 43210 —
First Surgical Hospital Bellaire Texas 77401 —
Legent Orthopedic Hospital Carrollton Texas 75006 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Memorial Hermann Village Houston Texas 77043 —
Clinical Trials of Texas, LLC San Antonio Texas 78229 —
Endeavor Clinical Trials, LLC San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05486416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05486416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →